» Articles » PMID: 10587576

NF1 Microdeletion Breakpoints Are Clustered at Flanking Repetitive Sequences

Overview
Journal Hum Mol Genet
Date 1999 Dec 10
PMID 10587576
Citations 55
Authors
Affiliations
Soon will be listed here.
Abstract

Neurofibromatosis type 1 patients with a submicroscopic deletion spanning the NF1 tumor suppressor gene are remarkable for an early age at onset of cutaneous neurofibromas, suggesting the deletion of an additional locus that potentiates neurofibromagenesis. Construction of a 3.5 Mb BAC/PAC/YAC contig at chromosome 17q11.2 and analysis of somatic cell hybrids from microdeletion patients showed that 14 of 17 cases had deletions of 1.5 Mb in length. The deletions encompassed the entire 350 kb NF1 gene, three additional genes, one pseudogene and 16 expressed sequence tags (ESTs). In these cases, both proximal and distal breakpoints mapped at chromosomal regions of high identity, termed NF1REPs. These REPs, or clusters of paralogous loci, are 15-100 kb and harbor at least four ESTs and an expressed SH3GL pseudogene. The remaining three patients had at least one breakpoint outside an NF1REP element; one had a smaller deletion thereby narrowing the critical region harboring the putative locus that exacerbates neurofibroma development to 1 Mb. These data show that the likely mechanism of NF1 microdeletion is homologous recombination between NF1REPs on sister chromatids. NF1 microdeletion is the first REP-mediated rearrangement identified that results in loss of a tumor suppressor gene. Therefore, in addition to the germline rearrangements reported here, NF1REP-mediated somatic recombination could be an important mechanism for the loss of heterozygosity at NF1 in tumors of NF1 patients.

Citing Articles

Cutaneous Neurofibroma Heterogeneity: Factors that Influence Tumor Burden in Neurofibromatosis Type 1.

Jiang C, McKay R, Lee S, Romo C, Blakeley J, Haniffa M J Invest Dermatol. 2023; 143(8):1369-1377.

PMID: 37318402 PMC: 11173230. DOI: 10.1016/j.jid.2022.12.027.


SUZ12 Loss Amplifies the Ras/ERK Pathway by Activating Adenylate Cyclase 1 in NF1-Associated Neurofibromas.

Li W, Hu C, Zhang X, Wang B, Li Z, Ling M Front Oncol. 2021; 11:738300.

PMID: 34692515 PMC: 8526866. DOI: 10.3389/fonc.2021.738300.


Atypical Microdeletions: Challenges and Opportunities for Genotype/Phenotype Correlations in Patients with Large Deletions.

Kehrer-Sawatzki H, Wahllander U, Cooper D, Mautner V Genes (Basel). 2021; 12(10).

PMID: 34681033 PMC: 8535936. DOI: 10.3390/genes12101639.


Integrated analysis reveals distinct molecular, clinical, and immunological features of B7-H3 in acute myeloid leukemia.

Zhang L, Jin Y, Xia P, Lin J, Ma J, Li T Cancer Med. 2021; 10(21):7831-7846.

PMID: 34562306 PMC: 8559480. DOI: 10.1002/cam4.4284.


Classification of NF1 microdeletions and its importance for establishing genotype/phenotype correlations in patients with NF1 microdeletions.

Kehrer-Sawatzki H, Cooper D Hum Genet. 2021; 140(12):1635-1649.

PMID: 34535841 PMC: 8553723. DOI: 10.1007/s00439-021-02363-3.